Amphastar P (AMPH)

Working capital turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	644,395	601,313	540,886	518,641	498,987	484,851	476,920	455,116	437,768	412,802	384,035	368,178	349,846	337,308	334,014	327,255	322,357	328,664	324,070	316,063
Total current assets	US$ in thousands	489,600	543,005	384,554	407,670	378,319	384,222	377,145	364,415	318,119	303,671	310,973	300,164	279,682	276,541	266,821	246,724	255,241	268,903	284,134	230,143
Total current liabilities	US$ in thousands	225,407	257,963	251,285	105,635	94,862	102,190	103,634	114,364	103,810	97,989	124,549	127,096	112,201	96,717	93,286	83,371	90,009	86,596	100,999	111,959
Working capital turnover		2.44	2.11	4.06	1.72	1.76	1.72	1.74	1.82	2.04	2.01	2.06	2.13	2.09	1.88	1.92	2.00	1.95	1.80	1.77	2.67

December 31, 2023 calculation

Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $644,395K ÷ ($489,600K – $225,407K)
= 2.44

The working capital turnover for Amphastar Pharmaceuticals Inc has shown fluctuation over the past eight quarters, ranging from 1.72 to 4.06. The working capital turnover measures a company's ability to efficiently utilize its working capital to generate revenue.

A higher working capital turnover ratio indicates that the company is effectively using its working capital to support its operations and generate sales. In contrast, a lower ratio may suggest inefficiencies in managing working capital.

In the most recent quarter, Q4 2023, the working capital turnover was 2.44, which reflects an improved efficiency in utilizing working capital compared to the previous quarters. This increase in efficiency could be attributed to better management of inventory, accounts receivable, and accounts payable.

Overall, the trend in working capital turnover for Amphastar Pharmaceuticals Inc indicates some variability in efficiency over the past quarters. Further analysis of the company's working capital management practices and operational strategies may help in better understanding the factors influencing these fluctuations.